US Patent 7427610 2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour action
Patent 7427610 was granted and assigned to Sterix Limited on September, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Alexander Hillisch0
Christian Gege0
Dirk Kosemund0
Eberhard Unger0
Gerhard Siemeister0
Olaf Peters0
Ulrich Bothe0
Wilko Regenhardt0
Edits on 14 Sep, 2023
Golden AI
Edits made to:
Article (+51 characters)
Article
Patent abstract
Disclosed are compounds of formula I
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07427610 2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour action US Patent 7427610 2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour action
Infobox
Patent Number
074276100
Patent Number
74276100
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074276100
Date of Patent
September 23, 2008
0Patent Application Number
105460300
Date Filed
February 19, 2004
0Official Website
Patent Primary Examiner
Edits on 14 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 1 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07427610 2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour action
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07427610
Date of patent
September 23, 2008
Patent application number
10546030
Date Filed
February 19, 2004
Patent primary examiner
Find more entities like US Patent 7427610 2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour action
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.